Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 972040, 10 pages
http://dx.doi.org/10.1155/2015/972040
Research Article

Induction of Thioredoxin Reductase 1 by Korean Red Ginseng Water Extract Regulates Cytoprotective Effects on Human Endothelial Cells

1Department of Microbiology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
2Department of Physiology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea

Received 31 March 2015; Accepted 18 June 2015

Academic Editor: Maria Camilla Bergonzi

Copyright © 2015 Hye Rim Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Schalkwijk and C. D. A. Stehouwer, “Vascular complications in diabetes mellitus: the role of endothelial dysfunction,” Clinical Science, vol. 109, no. 2, pp. 143–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. R. Park, H. Yang, G.-D. Kim, G. W. Son, and Y. S. Park, “Microarray analysis of gene expression in 3-methylcholanthrene-treated human endothelial cells,” Molecular & Cellular Toxicology, vol. 10, no. 1, pp. 19–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. E. Sumpio, J. Timothy Riley, and A. Dardik, “Cells in focus: endothelial cell,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 12, pp. 1508–1512, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Sena, A. M. Pereira, and R. Seiça, “Endothelial dysfunction—a major mediator of diabetic vascular disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 12, pp. 2216–2231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Rajendran, T. Rengarajan, J. Thangavel et al., “The vascular endothelium and human diseases,” International Journal of Biological Sciences, vol. 9, no. 10, pp. 1057–1069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. S. Park, J. Kim, Y. Misonou et al., “Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 6, pp. 1319–1325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. V. M. Victor, M. Rocha, E. Solá, C. Bañuls, K. Garcia-Malpartida, and A. Hernández-Mijares, “Oxidative stress, endothelial dysfunction and atherosclerosis,” Current Pharmaceutical Design, vol. 15, no. 26, pp. 2988–3002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Roberts and K. E. Porter, “Cellular and molecular mechanisms of endothelial dysfunction in diabetes,” Diabetes and Vascular Disease Research, vol. 10, no. 6, pp. 472–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. S. Sander, H. Chang, F. Hamm, P. Elsner, and J. J. Thiele, “Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis,” International Journal of Dermatology, vol. 43, no. 5, pp. 326–335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Yang, S. E. Lee, S. I. Jeong, C.-S. Park, Y.-H. Jin, and Y. S. Park, “Up-regulation of heme oxygenase-1 by Korean red ginseng water extract as a cytoprotective efect in human endothelial cells,” Journal of Ginseng Research, vol. 35, no. 3, pp. 352–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lee, J.-Y. Cho, and W.-K. Kim, “Anti-inflammation effect of exercise and Korean red ginseng in aging model rats with diet-induced atherosclerosis,” Nutrition Research and Practice, vol. 8, no. 3, pp. 284–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. H. Jeon, C. S. Kim, H.-S. Kim, J.-B. Park, K. Y. Nam, and S.-J. Chang, “Effect of Korean red ginseng on blood pressure and nitric oxide production,” Acta Pharmacologica Sinica, vol. 21, no. 12, pp. 1095–1100, 2000. View at Google Scholar · View at Scopus
  14. C. S. Kim, J. B. Park, K.-J. Kim, S. J. Chang, S.-W. Ryoo, and B. H. Jeon, “Effect of Korea red ginseng on cerebral blood flow and superoxide production,” Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1152–1156, 2002. View at Google Scholar · View at Scopus
  15. E. Jovanovski, V. Peeva, J. L. Sievenpiper et al., “Modulation of endothelial function by korean red ginseng (Panax ginseng C.A. meyer) and its components in healthy individuals: a randomized controlled trial,” Cardiovascular Therapeutics, vol. 32, no. 4, pp. 163–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. H. Kwok, W. Y. Ng, M. S. M. Yang, N. K. Mak, R. N. S. Wong, and P. Y. K. Yue, “The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status,” Free Radical Biology and Medicine, vol. 48, no. 3, pp. 437–445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Lee and Y. S. Park, “Korean red ginseng water extract inhibits COX-2 expression by suppressing p38 in acrolein-treated human endothelial cells,” Journal of Ginseng Research, vol. 38, no. 1, pp. 34–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Jovanovski, A. Jenkins, A. G. Dias et al., “Effects of korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals,” American Journal of Hypertension, vol. 23, no. 5, pp. 469–472, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Sung, K.-H. Han, J.-H. Zo, H.-J. Park, C.-H. Kim, and B.-H. Oh, “Effects of red ginseng upon vascular endothelial function in patients with essential hypertension,” The American Journal of Chinese Medicine, vol. 28, no. 2, pp. 205–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Cunniff, G. W. Snider, N. Fredette, J. Stumpff, R. J. Hondal, and N. H. Heintz, “Resolution of oxidative stress by thioredoxin reductase: cysteine versus selenocysteine,” Redox Biology, vol. 2, no. 1, pp. 475–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-H. Jan, D. E. Heck, A.-C. Dragomir, C. R. Gardner, D. L. Laskin, and J. D. Laskin, “Acetaminophen reactive intermediates target hepatic thioredoxin reductase,” Chemical Research in Toxicology, vol. 27, no. 5, pp. 882–894, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Fan, W. Zheng, X. Fu, X. Li, Y.-S. Wong, and T. Chen, “Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo,” Cell Death and Disease, vol. 5, no. 4, Article ID e1191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Lu and A. Holmgren, “The thioredoxin antioxidant system,” Free Radical Biology and Medicine, vol. 66, pp. 75–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Karimpour, J. Lou, L. L. Lin et al., “Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation,” Oncogene, vol. 21, no. 41, pp. 6317–6327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Du, Y. Wu, X. Cao et al., “Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions,” Biochimie, vol. 91, no. 3, pp. 434–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. S. Park, Y. Misonou, N. Fujiwara et al., “Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells,” Biochemical and Biophysical Research Communications, vol. 327, no. 4, pp. 1058–1065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A.-K. Rundlöf and E. S. J. Arnér, “Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events,” Antioxidants and Redox Signaling, vol. 6, no. 1, pp. 41–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. F. D. Mahmood, A. Abderrazak, K. El Hadri, T. Simmet, and M. Rouis, “The thioredoxin system as a therapeutic target in human health and disease,” Antioxidants and Redox Signaling, vol. 19, no. 11, pp. 1266–1303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. K. Kim, Q. Guo, and L. Packer, “Free radical scavenging activity of red ginseng aqueous extracts,” Toxicology, vol. 172, no. 2, pp. 149–156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Soini, K. Kahlos, U. Näpänkangas et al., “Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma,” Clinical Cancer Research, vol. 7, no. 6, pp. 1750–1757, 2001. View at Google Scholar · View at Scopus
  31. S. E. Lee, S. I. Jeong, G.-D. Kim et al., “Upregulation of heme oxygenase-1 as an adaptive mechanism for protection against crotonaldehyde in human umbilical vein endothelial cells,” Toxicology Letters, vol. 201, no. 3, pp. 240–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-I. Ryu, Y.-H. Park, H. C. Bae et al., “ZnO nanoparticle induces apoptosis by ROS triggered mitochondrial pathway in human keratinocytes,” Molecular and Cellular Toxicology, vol. 10, no. 4, pp. 387–391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. B. R. Xin, J. F. Liu, J. Kang, and W. P. Chan, “(2R,3S)-pinobanksin-3-cinnamate, a new flavonone from seeds of Alpinia galanga willd., presents in vitro neuroprotective effects,” Molecular & Cellular Toxicology, vol. 10, no. 2, pp. 165–172, 2014. View at Google Scholar
  34. S.-H. Kim, J.-W. Ko, S.-K. Koh et al., “Silver nanoparticles induce apoptotic cell death in cultured cerebral cortical neurons,” Molecular & Cellular Toxicology, vol. 10, no. 2, pp. 173–179, 2014. View at Publisher · View at Google Scholar
  35. Y. Gui and G. H. Ryu, “The effect of extrusion conditions on the acidic polysaccharide, ginsenoside contents and antioxidant properties of extruded Korean red ginseng,” Journal of Ginseng Research, vol. 37, no. 2, pp. 219–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Y. Nam, “The comparative understanding between red ginseng and white ginseng, processed ginseng (Panax ginseng C.A Meyer),” Journal of Ginseng Research, vol. 29, no. 1, pp. 1–18, 2005. View at Google Scholar
  37. S. Shin, J. Y. Jang, D. Park et al., “Korean red ginseng extract does not cause embryo-fetal death or abnormalities in mice,” Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol. 89, no. 1, pp. 78–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. B. Park, S. K. Kwon, H. Nagar et al., “Rg3-enriched Korean Red Ginseng improves vascular function in spontaneously hypertensive rats,” Journal of Ginseng Research, vol. 38, no. 4, pp. 244–250, 2014. View at Publisher · View at Google Scholar
  39. Z. Song, Y. Liu, B. Hao et al., “Ginsenoside Rb1 prevents H2O2-induced HUVEC senescence by stimulating sirtuin-1 pathway,” PLoS ONE, vol. 9, no. 11, Article ID e112699, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-K. Min, J.-H. Kim, Y.-L. Cho et al., “20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway,” Biochemical and Biophysical Research Communications, vol. 349, no. 3, pp. 987–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Choi, R. C. Tostes, and R. C. Webb, “Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta,” Journal of Cardiovascular Pharmacology, vol. 58, no. 5, pp. 522–527, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Lu, L. V. Papp, J. Fang, S. Rodriguez-Nieto, B. Zhivotovsky, and A. Holmgren, “Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity,” Cancer Research, vol. 66, no. 8, pp. 4410–4418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Sakurai, M. Nishimoto, S. Himeno et al., “Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2,” Journal of Cellular Physiology, vol. 203, no. 3, pp. 529–537, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Cunniff, G. W. Snider, N. Fredette, R. J. Hondal, and N. H. Heintz, “A direct and continuous assay for the determination of thioredoxin reductase activity in cell lysates,” Analytical Biochemistry, vol. 443, no. 1, pp. 34–40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Altschmied and J. Haendeler, “Thioredoxin-1 and endothelial cell aging: role in cardiovascular diseases,” Antioxidants and Redox Signaling, vol. 11, no. 7, pp. 1733–1740, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. R. Fernando, H. Nanri, S. Yoshitake, K. Nagata-Kuno, and S. Minakami, “Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells,” European Journal of Biochemistry, vol. 209, no. 3, pp. 917–922, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Sugahara, J. Nakanishi, and Y. Katsuta, “Kaempferol enhanced the intracellular thioredoxin system in normal cultured human keratinocytes,” Bioscience, Biotechnology, and Biochemistry, vol. 74, no. 8, pp. 1701–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus